1、Zhang YJ*, Zheng XF. . Targeting the mTOR kinase domain: the second generation of mTOR inhibitors. Drug Discov Today,2011;16(7-8):325-331
2、Zhang YJ#, Bao YJ, Dai Q, Yang WY, Cheng P, Zhu LM, Wang BJ, Jiang FH.. mTOR signaling is involved in indomethacin and nimesulide suppression of colorectal cancer cell growth via a COX-2 independent pathway. Ann Surg Oncol,2011;18(2):580-8
3、Cheng P, Jiang FH, Zhao LM, Dai Q, Yang WY, Zhu LM, Wang BJ, Xu C, Bao YJ, Zhang YJ#. Human macrophage metalloelastase correlates with angiogenesis and prognosis of gastric carcinoma. Dig Dis Sci,2010;55(11):3138-46.
4、Zhang YJ*, Dai Q, Tian XQ, Xiong H, Gao FH, Sun DF, Xu MH, Chen GQ, Han ZG, Fang JY.. mTOR Signaling Pathway is a Target for the Treatment of Colorectal Cancer. Ann Surg Oncol,2009;16(9):2617-28
5、Zhang YJ*, Tian XQ, Sun DF, Zhao SL, Xiong H, Fang JY. . Combined Inhibition of MEK and mTOR Signaling Inhibits Initiation and Progression of Colorectal Cancer. Cancer Invest,2009;27(3):273-85
6、Zhang YJ*, Zhao SL, Tian XQ, Sun DF, Xiong H, Dai Q, Li XQ, Fang JY. Combined Inhibition of Dnmt and mTOR Signaling Inhibits Formation and Growth of Colorectal Cancer. Int J Colorectal Dis,2009;24(6):629-39
7、Zhang YJ*, Dai Q, Wu SM, Zhu HY, Shen GF, Li EL, Xiao SD.. Susceptibility for NSAIDs-induced apoptosis correlates to p53 gene status in gastric cancer cells. 2008;. Cancer Invest,2008;26(9):868-77
8、Zhang YJ*, Fang JY.. Molecular staging of gastric cancer. J Gastroenterol Hepatol,2008;23(6):856-9
|
